Suppr超能文献

可切除胰腺导管腺癌经典预后因素的重新评估

Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.

作者信息

Åkerberg Daniel, Ansari Daniel, Andersson Roland

机构信息

Daniel Åkerberg, Daniel Ansari, Roland Andersson, Department of Surgery, Clinical Sciences Lund, Lund University, and Skåne University Hospital, SE-221 85 Lund, Sweden.

出版信息

World J Gastroenterol. 2016 Jul 28;22(28):6424-33. doi: 10.3748/wjg.v22.i28.6424.

Abstract

Pancreatic ductal adenocarcinoma carries a poor prognosis with annual deaths almost matching the reported incidence rates. Surgical resection offers the only potential cure. Yet, even among patients that undergo tumor resection, recurrence rates are high and long-term survival is scarce. Various tumor-related factors have been identified as predictors of survival after potentially curative resection. These factors include tumor size, lymph node disease, tumor grade, vascular invasion, perineural invasion and surgical resection margin. This article will re-evaluate the importance of these factors based on recent publications on the topic, with potential implications for treatment and outcome in patients with pancreatic cancer.

摘要

胰腺导管腺癌预后较差,每年的死亡人数几乎与报告的发病率相当。手术切除是唯一可能的治愈方法。然而,即使在接受肿瘤切除的患者中,复发率也很高,长期生存率很低。各种肿瘤相关因素已被确定为潜在根治性切除术后生存的预测指标。这些因素包括肿瘤大小、淋巴结病变、肿瘤分级、血管侵犯、神经周围侵犯和手术切缘。本文将根据该主题的最新出版物重新评估这些因素的重要性,这可能对胰腺癌患者的治疗和预后产生影响。

相似文献

1
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.
World J Gastroenterol. 2016 Jul 28;22(28):6424-33. doi: 10.3748/wjg.v22.i28.6424.
2
Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future.
Dig Liver Dis. 2018 Oct;50(10):979-990. doi: 10.1016/j.dld.2018.08.009. Epub 2018 Aug 20.
5
Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
Eur J Surg Oncol. 2014 Nov;40(11):1578-85. doi: 10.1016/j.ejso.2014.04.012. Epub 2014 May 21.
7
Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
Surgery. 2012 Sep;152(3 Suppl 1):S112-9. doi: 10.1016/j.surg.2012.05.017. Epub 2012 Jul 3.
10
Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
Ann Surg Oncol. 2015 Apr;22(4):1160-7. doi: 10.1245/s10434-014-4196-2. Epub 2014 Oct 28.

引用本文的文献

1
Regulation of pancreatic cancer cells by suppressing KIN17 through the PI3K/AKT/mTOR signaling pathway.
Oncol Rep. 2025 Feb;53(2). doi: 10.3892/or.2025.8864. Epub 2025 Jan 10.
7
Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis.
World J Gastrointest Oncol. 2022 Oct 15;14(10):1903-1917. doi: 10.4251/wjgo.v14.i10.1903.
9
The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection.
Ann Surg Oncol. 2020 Jun;27(6):2017-2024. doi: 10.1245/s10434-019-08161-6. Epub 2020 Jan 3.

本文引用的文献

1
Long-term trends in the incidence and relative survival of pancreatic cancer in Canada: A population-based study.
Pancreatology. 2016 Mar-Apr;16(2):259-65. doi: 10.1016/j.pan.2015.12.180. Epub 2016 Jan 12.
7
Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.
JAMA Surg. 2015 Aug;150(8):701-10. doi: 10.1001/jamasurg.2015.0668.
8
Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.
Br J Surg. 2015 Jun;102(7):837-46. doi: 10.1002/bjs.9799. Epub 2015 Apr 15.
9
Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
World J Gastroenterol. 2015 Jan 7;21(1):262-8. doi: 10.3748/wjg.v21.i1.262.
10
Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.
J Gastroenterol. 2015 Jun;50(6):694-702. doi: 10.1007/s00535-014-1005-4. Epub 2014 Oct 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验